Eileen J. Kennedy, Ph.D.
Affiliations: | 2000-2005 | Chemistry and biochemistry | University of California, San Diego, La Jolla, CA |
| 2006-2010 | Chemistry and Chemical Biology | Harvard University, Cambridge, MA, United States | |
| 2010- | Pharmaceutical and Biomedical Sciences | University of Georgia, Athens, Athens, GA, United States |
Area:
constrained peptides, kinases, kinase signaling, protein-protein interactionsWebsite:
http://pbs.rx.uga.edu/people/faculty-members/eileen-kennedy/Google:
"eileen j kennedy"Mean distance: 10.13 | S | N | B | C | P |
Parents
Sign in to add mentor| Gourisankar Ghosh | grad student | 2005 | UCSD | |
| (Understanding modulation of nucleotide binding by PKA and regulation of extracellular nucleotides in Saccharomyces cerevisiae.) | ||||
| Gregory L. Verdine | post-doc | 2006-2010 | Harvard | |
Children
Sign in to add trainee| Laura Hanold | grad student | University of Georgia | |
| Yuxiao Wang | grad student | University of Georgia | |
| Ameya J. Limaye | grad student | 2017-2022 | University of Georgia |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Alexander KK, Naaldijk Y, Fasiczka R, et al. (2023) Targeting Rab-RILPL interactions as a strategy to downregulate pathogenic LRRK2 in Parkinson's disease. Journal of Peptide Science : An Official Publication of the European Peptide Society. e3563 |
| Pathak P, Alexander KK, Helton LG, et al. (2023) Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) Dimerization. Acs Chemical Neuroscience |
| Limaye AJ, Whittaker MK, Bendzunas GN, et al. (2022) Targeting the WASF3 Complex to Suppress Metastasis. Pharmacological Research. 106302 |
| Limaye AJ, Bendzunas GN, Whittaker MK, et al. (2022) Optimized Stapled Peptides Targeting WASF3 in Breast Cancer. Acs Medicinal Chemistry Letters. 13: 570-576 |
| Byrne DP, Omar MH, Kennedy EJ, et al. (2022) Biochemical Analysis of AKAP-Anchored PKA Signaling Complexes. Methods in Molecular Biology (Clifton, N.J.). 2483: 297-317 |
| Singh RK, Soliman A, Guaitoli G, et al. (2022) Nanobodies as allosteric modulators of Parkinson's disease-associated LRRK2. Proceedings of the National Academy of Sciences of the United States of America. 119 |
| Helton LG, Soliman A, von Zweydorf F, et al. (2021) Allosteric Inhibition of Parkinson's-Linked LRRK2 by Constrained Peptides. Acs Chemical Biology |
| Limaye AJ, Bendzunas GN, Kennedy EJ. (2021) Targeted disruption of PKC from AKAP signaling complexes. Rsc Chemical Biology. 2: 1227-1231 |
| Lasonder E, More K, Singh S, et al. (2021) cAMP-Dependent Signaling Pathways as Potential Targets for Inhibition of Blood Stages. Frontiers in Microbiology. 12: 684005 |
| Baffi TR, Lordén G, Wozniak JM, et al. (2021) mTORC2 controls the activity of PKC and Akt by phosphorylating a conserved TOR interaction motif. Science Signaling. 14 |